Claim Missing Document
Check
Articles

Found 4 Documents
Search

Central Venous Disease in Hemodialysis Patients: A Comprehensive Systematic Review of Pathophysiology, Management, and Outcomes Edelwis Christine; Charles Sanjaya
The International Journal of Medical Science and Health Research Vol. 17 No. 1 (2025): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/9qtn3g23

Abstract

INTRODUCTION: Central Venous Disease (CVD), encompassing stenosis and occlusion of major thoracic veins, represents a critical challenge in the management of hemodialysis (HD) patients. It is a leading cause of vascular access dysfunction, contributing to significant morbidity, inadequate dialysis delivery, and compromised quality of life. This review systematically evaluates the evidence base for the pathophysiology, diagnosis, and management of CVD in this vulnerable population. METHODS: A systematic literature search was conducted across PubMed, Google Scholar, Semanthic Scholar, Springer, Wiley Online Library for cohort studies, randomized controlled trials (RCTs), and systematic reviews published between 1995 and 2024. Studies were included if they evaluated risk factors or treatment outcomes for CVD in adult HD patients. Primary outcomes analyzed were technical success, clinical success, primary patency, assisted-primary patency, and secondary patency. Secondary outcomes included complication rates and re-intervention frequency. Study quality was assessed using the Cochrane Risk of Bias tool for RCTs and the Newcastle-Ottawa Scale for observational studies. RESULTS: Seventeen studies met the inclusion criteria for detailed outcome analysis, supplemented by numerous others for epidemiological and pathophysiological context. The evidence overwhelmingly identifies prior central venous catheter (CVC) placement as the principal risk factor for CVD, with risk increasing with catheter duration and number of placements. Endovascular therapy is the first-line treatment for symptomatic lesions. Comparative analysis revealed that while percutaneous transluminal angioplasty (PTA) has high initial success, it suffers from poor long-term primary patency (21-29% at 12 months). Stent grafts (SGs) demonstrate significantly superior primary patency (84-100% at 12 months) compared to both PTA and bare-metal stents (BMS). Drug-coated balloons (DCBs) show promise over PTA but require further validation in central venous anatomy. Surgical bypass remains a viable salvage option for refractory cases. DISCUSSION: The pathogenesis of CVD is a CVC-driven process of endothelial injury and neointimal hyperplasia, exacerbated by high access flow. The management paradigm has shifted from PTA-dominant strategies to a more durable, device-oriented approach, with SGs offering the best primary patency. However, high rates of re-intervention across all modalities underscore the recalcitrant nature of the disease, highlighting a critical need for preventative strategies centered on CVC avoidance. CONCLUSION: CVD is a frequent and serious complication in HD patients, primarily caused by CVCs. While endovascular interventions can effectively manage symptomatic lesions, SGs provide the most durable outcomes. The cornerstone of management should be prevention through timely creation of permanent vascular access.
Fecal Calprotectin: A Comprehensive Systematic Review of Its Diagnostic and Monitoring Efficacy in Inflammatory Bowel Disease Emilia Fitri Annisa; Charles Sanjaya
The International Journal of Medical Science and Health Research Vol. 19 No. 4 (2025): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/x6r8d759

Abstract

Introduction Inflammatory Bowel Disease (IBD), encompassing Ulcerative Colitis (UC) and Crohn's Disease (CD), is a chronic, relapsing condition demanding continuous, objective surveillance of mucosal inflammation. Due to the burdens associated with invasive endoscopy—the conventional gold standard for assessment—there is a critical need for accurate, non-invasive biomarkers. Fecal Calprotectin (FC), a stable protein released by activated neutrophils, serves as a quantitative surrogate marker that directly correlates with the level and extent of gastrointestinal inflammation. This comprehensive systematic review aggregates high-level meta-analytic evidence to define the precise utility of FC across IBD diagnosis, therapeutic monitoring, and prediction of long-term disease course. Methods This systematic review synthesized quantitative findings from high-quality diagnostic accuracy and prognostic meta-analyses, encompassing data pooled from over fifteen primary studies focusing on adults and children with IBD. The underlying systematic searches utilized extensive database coverage, including PubMed, Google Scholar, Semantic Scholar, Springer, Wiley Online Library. Key performance metrics rigorously extracted included pooled sensitivity, specificity, Area Under the Summary Receiver Operating Characteristic Curve (AUROC), Diagnostic Odds Ratio (DOR), Positive Likelihood Ratio (PLR), and Negative Likelihood Ratio (NLR). The methodological rigor of the aggregated evidence was assessed using the QUADAS-2 framework. Results FC demonstrated superior accuracy for differentiating IBD from functional gastrointestinal disorders. At the standard 50 mug/g cut-off, pooled analyses yield high sensitivity (89% to 99%) and a critically high Negative Predictive Value (NPV) of 0.99 for IBD exclusion. In monitoring, FC reliably correlates with endoscopic activity, with optimal performance in UC (AUROC 0.97) but diminished utility in isolated small bowel CD (SB-CD), where the AUROC drops to 0.72 at the 100 mug/g cut-off. For prognostic assessment, the optimal pooled cut-off of 152 mug/g for predicting clinical relapse in adult UC patients in remission yields a robust DOR of 10.54. Furthermore, distinct concentration ranges define Mucosal Healing (MH) targets: 60-75 mug/g for UC (AUC 0.88) versus a higher 180-250 mug/g range for CD (AUC 0.79). Discussion FC is confirmed as an essential biomarker, yet its optimal implementation requires careful consideration of its limitations, including significant quantitative variability (up to 5-fold differences) across commercial assays, which hinders the universal application of precise meta-analytic thresholds. The physiological barrier in detecting proximal small bowel inflammation necessitates integrating FC results with cross-sectional imaging and exploring complementary serum biomarkers. The greatest clinical value of FC lies in its use for continuous, longitudinal surveillance to proactively guide therapeutic intensification and reduce the need for unnecessary endoscopic procedures. Conclusion and Recommendations Fecal Calprotectin is established as an indispensable, non-invasive biomarker for IBD triage and continuous surveillance. Its clinical efficacy is maximized through the meticulous application of phenotype- and location-specific cut-offs tailored to the specific clinical query (diagnosis, MH, or relapse prediction). Standardizing commercial FC assays remains the most crucial outstanding challenge to ensure the consistent, reliable, and interchangeable application of these evidence-based thresholds across global healthcare settings.
The Comprehensive Systematic Review of What is The Relationship Between Pleural Effusion Characteristics and The Occurrence of Compressive Atelectasis in Adult Patients, as Evaluated Through Radiological Imaging Techniques? Anisa Ayu Prasanti; Charles Sanjaya
The International Journal of Medical Science and Health Research Vol. 26 No. 2 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/dzn49b80

Abstract

Introduction: Pleural effusions are a common clinical finding across diverse medical and surgical conditions, often leading to respiratory compromise. Compressive atelectasis, the collapse of lung tissue due to external pressure from pleural fluid, is a significant contributor to this morbidity. However, the precise relationship between specific characteristics of the effusion (e.g., volume, composition, laterality) and the occurrence of compressive atelectasis remains inadequately defined in adult populations (Chiumello et al., 2013; Muruganandan et al., 2020). Methods: A comprehensive systematic review was conducted, screening sources based on predefined criteria including adult population, presence of pleural effusion, assessment of effusion characteristics, evaluation of compressive atelectasis via radiological imaging, and appropriate study designs. Data were extracted from 80 heterogeneous sources, encompassing observational studies, randomized trials, and meta-analyses, focusing on population details, effusion characteristics, imaging methods, atelectasis definitions, and reported statistical relationships. Results: Direct evidence quantitatively linking effusion characteristics to compressive atelectasis was scarce. Larger effusion size (e.g., >500 mL) was associated with increased incidence of atelectasis, particularly in specific populations like lung transplant recipients (Krumm et al., 2024). Indirect evidence from drainage studies showed consistent improvements in oxygenation (PaO2/FiO2 ratio) and end-expiratory lung volume post-thoracentesis, especially in mechanically ventilated patients with hypoxemia (Goligher et al., 2011; Vetrugno et al., 2019; Chiu et al., 2024). Key thresholds emerged, suggesting drainage is most beneficial for effusions >400-500 mL or occupying ≥25% of the hemithorax, particularly when baseline P:F ratio is <200. The relationship is modulated by factors such as body position, underlying lung and pleural disease (e.g., trapped lung), and effusion etiology (Cortes-Puentes et al., 2018; Razazi et al., 2014). Discussion: The findings indicate that the development of compressive atelectasis is a multifactorial process, not solely dependent on effusion volume. Underlying pleural physiology (elastance), parenchymal compliance, patient positioning, and diaphragm function critically influence the outcome. Radiographic lung re-expansion post-drainage is a poor surrogate for physiological success, often discordant with pleural pressure measurements (Lester et al., 2022). The clinical implication is that management should be guided by physiology and symptoms, not just imaging appearance. Conclusion: While larger pleural effusions increase the risk of compressive atelectasis, the relationship is non-linear and significantly confounded by patient-specific factors. A standardized definition for compressive atelectasis and more studies directly correlating detailed effusion characteristics with radiologically defined atelectasis are needed. Clinically, drainage should be considered for symptomatic patients or mechanically ventilated patients with significant hypoxemia and effusions above volume thresholds, with an understanding that underlying lung condition dictates the response.
Pendekatan Terintegrasi Intermittent Fasting, Diet Rendah Karbohidrat, dan Aktivitas Fisik dalam Memperbaiki Obesitas, Hipertensi, dan Gangguan Glikemik: Sebuah Laporan Kasus Sulastri; Charles Sanjaya
The Indonesian Journal of General Medicine Vol. 24 No. 1 (2026): The Indonesian Journal of General Medicine
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/zfpywk96

Abstract

Obesitas, hipertensi, dan gangguan glikemik merupakan masalah kardiometabolik yang sering terjadi bersamaan dan saling memperberat risiko penyakit kardiovaskular. Perubahan gaya hidup menjadi pilar utama tatalaksana, namun laporan kasus yang menggambarkan pendekatan terintegrasi secara praktis di layanan primer masih terbatas. Laporan kasus ini bertujuan untuk menggambarkan hasil klinis penerapan pendekatan terintegrasi berupa intermittent fasting, diet rendah karbohidrat, aktivitas fisik teratur, dan terapi antihipertensi tunggal pada pasien dengan obesitas, hipertensi, dan gangguan glikemik. Seorang perempuan usia 39 tahun dengan obesitas, hipertensi stage 2, dan kadar gula darah sewaktu meningkat menjalani pemantauan selama enam bulan di fasilitas pelayanan kesehatan primer. Pada awal observasi, pasien memiliki berat badan 105 kg, lingkar perut 105 cm, tekanan darah 180/100 mmHg, gula darah sewaktu 248 mg/dl, dan kolesterol total 210 mg/dl. Intervensi yang diberikan meliputi intermittent fasting pola 16:8, diet rendah karbohidrat dengan pengurangan makanan olahan, aktivitas fisik intensitas sedang berupa jalan santai selama satu jam sebanyak tiga kali seminggu, serta terapi farmakologis candesartan 8 mg satu kali sehari. Selama periode observasi enam bulan, terjadi perbaikan klinis yang konsisten dan bermakna. Berat badan menurun menjadi 85 kg, lingkar perut menjadi 98 cm, tekanan darah menjadi 120/90 mmHg, gula darah sewaktu menjadi 140 mg/dl, dan kolesterol total menjadi 156 mg/dl. Pasien menunjukkan kepatuhan yang baik terhadap intervensi dan tidak mengalami efek samping bermakna. Pendekatan terintegrasi yang mengombinasikan perubahan gaya hidup terstruktur dan terapi farmakologis minimal terbukti efektif dalam memperbaiki parameter kardiometabolik pada pasien usia produktif, serta berpotensi diterapkan secara luas di layanan primer.